Huang, Chang
Helin, Kristian http://orcid.org/0000-0003-1975-6097
Funding for this research was provided by:
Institute of Cancer Research, Royal Cancer Hospital
Article History
First Online: 6 April 2023
Competing interests
: K.H. is a co-founder of Dania Therapeutics and a scientific advisor for Hannibal Innovation. He was recently a scientific advisor for Inthera Bioscience AG and MetaboMed Inc. C.H. declares no competing interests.